viernes, 13 de septiembre de 2024

FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause Stop medicine if signs and symptoms of liver injury occur

https://www.fda.gov/drugs/drug-safety-and-availability/fda-adds-warning-about-rare-occurrence-serious-liver-injury-use-veozah-fezolinetant-hot-flashes-due

No hay comentarios:

Publicar un comentario